Cancer inhibition by green tea

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 402, Issue 1-2, 1998, Pages 307-310

  Fujiki, Hirota ^a   Suganuma, Masami ^a   Okabe, Sachiko ^a   Sueoka, Naoko ^a   Komori, Atsumasa ^a   Sueoka, Eisaburo ^a   Kozu, Tomoko ^a   Tada, Yukiko ^a   Suga, Kenji ^a   Imai, Kazue ^a   Nakachi, Kei ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Anticarcinogenic effect; Delayed cancer onset; EGCG; G2 M arrest; TNF

Indexed keywords

EPIGALLOCATECHIN GALLATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TEA;

3T3 CELLS; ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL AVAILABILITY; CATECHIN; FEMALE; HUMANS; MALE; MICE; NEOPLASMS; TEA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032543342     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00310-2     Document Type: Conference Paper

References (9)

1. [1] S. Yoshizawa, T. Horiuchi, H. Fujiki, T. Yoshida, T. Okuda, T. Sugimura, Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of 'Tannin' in green tea, Phytother. Res. 1 (1987) 44-47.
2. [2] S. Yoshizawa, T. Horiuchi, M. Suganuma, S. Nishiwaki, J. Yatsunami, S. Okabe, T. Okuda, Y. Muto, K. Frenkel, W. Troll, H. Fujiki, Penta-O-galloyl-β-D-glucose and (-)-epigallocatechin gallate, in: M.-T. Huang, C.-T. Ho, C.Y. Lee (Eds.), Phenolic Compounds in Food and Their Effect on Health II, ACS Symposium Series 507, USA (1992) pp. 316-325.
3. [3] H. Fujiki, A. Komori, M. Suganuma, Chemoprevention of cancer, in: T. Bowden, S. Fischer (Eds.), Comprehensive Toxicology, Elsevier, UK, 1997, 453-471.
4. [4] A. Komori, J. Yatsunami, S. Okabe, S. Abe, K. Hara, M. Suganuma, S.-J. Kim, H. Fujiki, Anticarcinogenic activity of green tea polyphenols, Jpn. J. Clin. Oncol. 23 (1993) 186-190.
5. [5] S. Okabe, M. Suganuma, M. Hayashi, E. Sueoka, A. Komori, H. Fujiki, Mechanisms of growth inhibition by tea polyphenols on human lung cancer cell line, PC-9, Jpn. J. Cancer Res. 88 (1997) 639-643.
6. [6] K. Imai, K. Nakachi, Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases, BMJ 310 (1995) 693-696.
7. [7] K. Nakachi, K. Imai, K. Suga, Epidemiological evidences for prevention of cancer and cardiovascular disease by drinking green tea, in: H. Ohigashi, T. Osamwa, J. Terao, S. Watanabe, T. Yoshikawa (Eds.), Food Factors For Cancer Prevention, Springer-Verlag Tokyo Press, 1997, 105-108.
8. [8] A. Komori, J. Yatsunami, M. Suganuma, S. Okabe, S. Abe, A. Sakai, K. Sasaki, H. Fujiki, Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation, Cancer Res. 53 (1993) 1982-1985.
9. [9] M. Suganuma, S. Okabe, E. Sueoka, N. Iida, A. Komori, S.-J. Kim, H. Fujiki, A new process of cancer prevention mediated through inhibition of tumor necrosis factor α expression, Cancer Res. 56 (1996) 3711-3715.